Toggle light / dark theme

Crispr’d Cells Show Promise in First US Human Safety Trial

Using genetically-edited cells to supercharge the immune system caused no adverse effects in cancer patients. It’s too soon to tell if it can be a cure.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.